Correlations Between Changes in Disability and T2-weighted Brain MRI Activity in Multiple Sclerosis: a Follow-up Study

Overview

Journal Neurology

Specialty Neurology

Date 1995 Feb 1

PMID 7854522

Citations 50

Authors

M Filippi

D W Paty

L Kappos

F Barkhof

D A Compston

A J Thompson

G J Zhao

C M Wiles

W I McDonald

D H Miller

Affiliations

Soon will be listed here.

Abstract

We obtained two conventional unenhanced T2-weighted brain MRI scans, separated by an interval of 24 to 36 months, in 281 patients with multiple sclerosis (MS). At the time of each scan, clinical disability was rated using the Kurtzke Expanded Disability Status Scale (EDSS). Changes in disability between the two examinations correlated weakly but significantly with the number of new (Spearman's rank correlation coefficient = 0.13; p = 0.02) and enlarging (Spearman's rank correlation coefficient = 0.18; p = 0.002) MRI lesions. This result suggests that brain T2-weighted MRI is a useful supplementary marker of disease activity in definitive (phase III) clinical treatment trials in MS.

Citing Articles

Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis.

Hoffmann O, Paul F, Haase R, Kern R, Ziemssen T Patient Prefer Adherence. 2024; 18:455-466.

PMID: 38406376 PMC: 10894675. DOI: 10.2147/PPA.S452849.

Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?.

Hoffmann O, Gold R, Meuth S, Linker R, Skripuletz T, Wiendl H Ther Adv Neurol Disord. 2024; 17:17562864241229325.

PMID: 38332854 PMC: 10851744. DOI: 10.1177/17562864241229325.

Machine learning-optimized Combinatorial MRI scale (COMRISv2) correlates highly with cognitive and physical disability scales in Multiple Sclerosis patients.

Kelly E, Varosanec M, Kosa P, Prchkovska V, Moreno-Dominguez D, Bielekova B Front Radiol. 2023; 2:1026442.

PMID: 37492667 PMC: 10365117. DOI: 10.3389/fradi.2022.1026442.

Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.

Pietroboni A, Colombi A, Contarino V, Lo Russo F, Conte G, Morabito A Eur Radiol. 2022; 33(8):5368-5377.

PMID: 36562783 DOI: 10.1007/s00330-022-09338-6.

Automated Registration and Color Labeling of Serial 3D Double Inversion Recovery MR Imaging for Detection of Lesion Progression in Multiple Sclerosis.

Park C, Brummer M, Sadigh G, Saindane A, Mullins M, Allen J J Digit Imaging. 2022; 36(2):450-457.

PMID: 36352165 PMC: 10039147. DOI: 10.1007/s10278-022-00737-1.